Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05537285 · ClinicalTrials.gov registry record · NA
Individualized Neuromodulation for Anhedonic Depression
A NA study, sponsored by University of California, San Diego.
- Completed
- Registry status
- NA
- Development phase
- 60
- Enrollment target
NCT05537285 is a NA study that has completed, run by University of California, San Diego. The registered enrollment target is 60 participants.
The verdict
NCT05537285, a NA study, has completed, sponsored by University of California, San Diego.
- COMPLETED
- Registry status
- NA
- Development phase
- 60 participants
- Enrollment target
Study Summary
This program of research constitutes a three-arm, randomized, placebo-controlled trial testing noninvasive brain stimulation for the treatment of anhedonic depression. This trial is part of a larger, three-site study that will be conducted at UCSD, Stanford University, and Cornell University, with the overarching goals to compare competing interventions tested at each site and to combine data that will allow for the creation of an end-to-end model of anhedonic depression. By doing this, the investigators hope to gain insight and lead to the development of brain-behavior biomarkers to identify who is best suited for the different treatment options tested at each site. An additional exploratory objective is phenotyping anhedonic depression from the acquired measures. Anhedonic patients recruited at UCSD will be randomized to one of three treatment arms to receive different forms of accelerated intermittent theta burst stimulation (aiTBS),a novel form of repetitive transcranial magnetic stimulation (rTMS) that is an FDA approved treatment for depression. These arms include: individualized accelerated iTBS (Ind-aiTBS),based on both the frequency of brain responses and electric-field (e-field) modeling of brain bioconductivity; standard accelerated iTBS (Std-aiTBS); and accelerated sham iTBS(sham). Treatment will be delivered on an accelerated schedule, over one week. Additional study sessions will occur both before and after treatment to assess for clinical, neurophysiological, and cognitive measures that will allow for both individualization of treatment and detailed assessment of the effects of the different treatment arms.
Interventions
- DEVICE Individualized Accelerated Intermittent Theta Burst Stimulation (Ind-aiTBS)
- DEVICE Standard Accelerated Intermittent Theta Burst Stimulation (Std-aiTBS)
- DEVICE Sham Accelerated Intermittent Theta Burst Stimulation (Sham)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 60 participants |
| Start Date | 2022-08-01 |
| Est. Completion | 2025-05-30 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05537285
The ClinicalTrials.gov registry entry for NCT05537285 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 60 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of California, San Diego, which has 775 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Individualized Accelerated Intermittent Theta Burst Stimulation (Ind-aiTBS) is the first listed.
NCT05537285 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05537285 about?
NCT05537285 is a clinical study titled "Individualized Neuromodulation for Anhedonic Depression". This program of research constitutes a three-arm, randomized, placebo-controlled trial testing noninvasive brain stimulation for the treatment of anhedonic depression. This trial is part of a larger, three-site study that will be conducted at UCSD, Stanford University, and Cornell University, with t...
What is the current status of trial NCT05537285?
This trial is currently completed. It is a NA study. The enrollment target is 60 participants. The study started on 2022-08-01. Estimated completion is 2025-05-30.
What interventions are being tested in trial NCT05537285?
The interventions under investigation include: Individualized Accelerated Intermittent Theta Burst Stimulation (Ind-aiTBS) (DEVICE), Standard Accelerated Intermittent Theta Burst Stimulation (Std-aiTBS) (DEVICE), Sham Accelerated Intermittent Theta Burst Stimulation (Sham) (DEVICE).
Who is sponsoring clinical trial NCT05537285?
This trial is sponsored by University of California, San Diego, which has 775 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.